Sign in
Taking peopleNo phase

Vivinex Impress XY1-EM vs RayOne EMV

Key facts

Who runs it
Medical University of Bialystok
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
1 Jan 2026
Expected to end
1 Jun 2028
Type of study
Interventional, 2 groups
Treatments tested
  • RayOne EMV
  • Vivinex Impress
Record updated
20 January 2026

Who can take part

Age
21 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • age-related bilateral cataract
  • age 21 or older
  • visual acuity > 0.05
  • axial length: 22.0 - 26.0 mm
  • normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
  • written informed consent prior to surgery

Who cannot take part

  • previous ocular surgery or trauma
  • active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication)
  • relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX), intraoperative floppy iris syndrome (IFIS)
  • corneal decompensation or corneal endothelial cell insufficiency
  • persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)
  • corneal astigmatism > 1 dpt
  • retinopathies

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 80 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract

The 2 groups in the trial

  • Rayone EMVTreatment being tested

    Patient will receive the non-diffractive monofocal IOL during cataract surgery

  • Vivinex Impress XY1-EMTreatment being tested

    Patient will receive the non-diffractive monofocal IOL during cataract surgery

    Treatment: Vivinex Impress

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Quality of Vision After Implantation of Monofocal Depth-enhanced Intraocular Lenses in Patients Undergoing Bilateral Cataract Surgery
Criteria questions
Built from NCT06891092, who can take part
Record updated
20 January 2026